SCOPOLAMINE TRANSDE

The Defense Logistics Agency awarded Delivery Order SPE2DP26F7520 to DMS PHARMACEUTICAL GROUP INC under the base contract SPE2DX25D9900 for the procurement of one unit of Scopolamine Transdermal (NSN 6505014562380) at a total price of $65.48. Delivery is required by July 29, 2026, to Fort Bragg, North Carolina, under FOB Destination terms, meaning the contractor assumes all transportation costs and risks until the item arrives at the specified location. The contractor, certified as a Small Business, Small Disadvantaged Business, and Women-Owned Small Business, must ship the product via the fastest traceable means, prohibiting parcel post, and ensure all packaging and documentation are clearly marked with the NSN, CAGE codes (1UNB0 and 3KJG9), and NDC numbers to support tracking and compliance with DoD supply standards. Inspection and acceptance occur at the delivery point by the Government, with final authority vested in the Contracting Officer Lisa Quinn. Payment will be processed through the Defense Finance and Accounting Service in Columbus, Ohio, using the specified accounting code BX: 97X4930 5CBX 001 2620 S33189. No additional contract clauses, special requirements, or attachments are explicitly included in the order, and no COTR or formal evaluation factors are documented, suggesting reliance on the foundational terms of the underlying IDIQ contract. The award was issued electronically through DIBBS on July 14, 2026, and the contractor is expected to meet all pharmaceutical procurement standards without specified MIL-STD references or additional quality testing protocols beyond conformance to contract requirements.